Soluble toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission

Holst, Benjamin, Szakmany, Tamas ORCID: https://orcid.org/0000-0003-3632-8844, Raby, Anne-Catherine ORCID: https://orcid.org/0000-0002-5354-5835, Hamlyn, Vincent, Durno, Kimberley, Hall, Judith Elizabeth ORCID: https://orcid.org/0000-0002-6770-7372 and Labéta, Mario O. 2017. Soluble toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission. Intensive Care Medicine Experimental 5 (1) 10.1186/s40635-016-0116-z

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (410kB) | Preview

Abstract

Soluble TLR2 levels are elevated in infective and inflammatory conditions, but its diagnostic value with sepsis-induced multi-organ failure has not been evaluated. 37 patients with a diagnosis of severe sepsis/septic shock (sepsis) and 27 patients with organ failure without infection (SIRS) were studied. Median (IQR) plasma sTLR2 levels were 2.7 ng/ml (1.4–6.1) in sepsis and 0.6 ng/ml (0.4–0.9) in SIRS p < 0.001. sTLR2 showed good diagnostic value for sepsis at cut-off of 1.0 ng/ml, AUC:0.959. We report the ability of sTLR2 levels to discriminate between sepsis and SIRS within 12 h of ICU admission in patients with multi-organ failure.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Springer
ISSN:	2197-425X
Funders:	Wellcome Trust
Date of First Compliant Deposit:	13 January 2017
Date of Acceptance:	29 December 2016
Last Modified:	23 May 2024 01:15
URI:	https://orca.cardiff.ac.uk/id/eprint/97414

Citation Data

Cited 14 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item